An Open Label Study to Investigate the Pharmacokinetics of CK-182745 Administered Orally to Patients With Stable Heart Failure.
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2013
At a glance
- Drugs Omecamtiv mecarbil (Primary)
- Indications Heart failure
- Focus Pharmacokinetics
- 05 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jul 2009 New trial record